Ali, S., Dunmore, H., Karres, D., Hay, J. L., Salmonsson, T., Gisselbrecht, C., . . . Pignatti, F. (2019). The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia. Oncologist.
Chicago ZitierstilAli, Sahra, et al. "The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia." Oncologist 2019.
MLA ZitierstilAli, Sahra, et al. "The EMA Review of Mylotarg (Gemtuzumab Ozogamicin) for the Treatment of Acute Myeloid Leukemia." Oncologist 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.